Physician profile
Jacob Edward Waldron
NPI 1326497504
$26,073.14
in general payments reported to CMS, 2019-2025
8 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $550 · 2022: $300 · 2023: $1,841 · 2024: $1,807 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $2,559 · Food and Beverage: $2,245 · Education: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $2,558.87 |
| Food and Beverage | $2,245.29 |
| Education | $418.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2025 | |
| Medical Device Business Services, INC. | $3,417.51 | 2021-2024 | Actis |
| Stryker Corporation | $1,493.84 | 2024-2025 | Alphavent, Gamma, Ortholoc 3di |
| Depuy Synthes Sales INC. | $597.33 | 2023-2025 | Na, Attune, Multiloc |
| Prodigy Surgical Distribution, INC. | $288.35 | 2025 | |
| Aroa Biosurgery Incorporated | $138.45 | 2024 | |
| Heron Therapeutics, INC. | $120.83 | 2024 | Zynrelef |
| Pinnacle, INC | $16.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.